Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_assertion type Assertion NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_head.
- NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_assertion description "[Our results demonstrate tumor-specific accumulation and therapeutic efficacy of radioiodine after MSC-mediated NIS gene delivery in HCC tumors, opening the prospect of NIS-mediated radionuclide therapy of metastatic cancer using MSCs as gene delivery vehicles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_provenance.
- NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_assertion evidence source_evidence_literature NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_provenance.
- NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_assertion SIO_000772 21587211 NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_provenance.
- NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_assertion wasDerivedFrom befree-20140225 NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_provenance.
- NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_assertion wasGeneratedBy ECO_0000203 NP440979.RAr2gBGkSrlQc2Og0CiNozxrDHkPDTAE3Jw2fA8BGLSlw130_provenance.